03513nas a2200265   4500000000100000008004100001260001200042653006000054653002400114653003900138653002400177653001800201653002100219100001600240700001300256700001200269700001400281700001600295245022400311856007800535300001200613490000700625520260100632022001403233       2022                            d  c03/202210aEDUCATION & TRAINING (see Medical Education & Training)10aInfectious Diseases10ainfectious diseases & infestations10aPreventive Medicine10aPublic health10awound management1 aNoordende A1 aAycheh M1 aMoges N1 aTadesse T1 aSchippers A00aFamily-based intervention for prevention and self-management of disabilities due to leprosy, podoconiosis and lymphatic filariasis versus usual care in Ethiopia: study protocol for a cluster-randomised controlled trial.  uhttps://bmjopen.bmj.com/content/bmjopen/12/3/e056620.full.pdf?with-ds=yes  ae0566200 v123 a<p><strong>INTRODUCTION: </strong>Leprosy, podoconiosis and lymphatic filariasis (LF) are three skin-related neglected tropical diseases. All three conditions can lead to temporary and permanent impairments. These impairments progressively worsen and are major determinants of stigma, discrimination and participation restrictions. Self-care is essential to prevent disabilities and chronic disease complications. Many persons with leprosy-related, LF-related and podoconiosis-related disabilities need to practice self-management routines their entire life. This is difficult without support and encouragement of others. The objective of this study was to assess the effectiveness of a family-based intervention in terms of physical outcomes related to prevention and self-management of disabilities due to leprosy, podoconiosis and LF and family quality of life and well-being compared with usual practice and care.</p>

<p><strong>METHODS AND ANALYSIS: </strong>The study will use a cluster-randomised controlled trial design with two study arms. The project will be carried out in endemic districts in East and West Gojjam zones in the Amhara region in Ethiopia. Clusters consist of kebeles (lower administrative structures in the district) that have been merged, based on their geographical proximity and the number of cases in each kebele. A total of 630 participants will be included in the study. The intervention group will consist of 105 persons affected by leprosy, 105 persons affected by LF or podoconiosis, and 210 family members. The control group will consist of 105 persons affected by leprosy and 105 persons affected by LF or podoconiosis. The family-based intervention comprises an essential care package that consists of the following three main components: (1) self-management of disabilities, (2) economic empowerment and (3) psychosocial support. Participants in the control areas will receive usual practice and care. Data analysis includes, but is not limited to, calculating the percentage of change and corresponding 95% CI of physical impairment outcomes in each group, before and after the intervention is implemented, effect sizes, intention to treat and difference in difference analysis.</p>

<p><strong>ETHICS AND DISSEMINATION: </strong>Ethical approval has been obtained from the Debre Markos University Health Sciences Institutional Research Ethics Review Committee. Results will be disseminated through peer-reviewed publications, conference presentations and workshops.</p>

<p><strong>TRIAL REGISTRATION NUMBER: </strong>PACTR202108907851342.</p>
  a2044-6055